Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Cancer Vaccines Market From 2025 To 2029?

Recently, there has been a swift expansion in the size of the cancer vaccines market. With an expected increase from $7.22 billion in 2024 to $8.25 billion in 2025, the market is projected to display a compound annual growth rate (CAGR) of 14.3%. The historic growth trajectory is tied to factors such as an upsurge in cancer incidence, heightened awareness about cancer vaccines, broadening portfolio of approved vaccines, accumulating proof of the effectiveness of such vaccines, and governmental backing for research and development.

What Is the Projected Market Size of the Cancer Vaccines Market?

Anticipations are high for significant expansion in the cancer vaccines market in the approaching years. The projections see the market soaring to $13.89 billion by 2029, advancing at a compound annual growth rate (CAGR) of 13.9%. The predicted expansion during the forecast period is credited to factors such as the use of cancer vaccines in combination therapies, heightened financial input by pharmaceutical firms, the emergence of biomarkers, tailor-made vaccines, and growing vaccine programs. The forecast period is also expected to witness several critical trends, including progress in immunology, supportive therapies, broadening of indications, patient accessibility, cooperative research, and the development of neoantigen-based and therapeutic cancer vaccines.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp

Who are the Major Competitors in the Cancer Vaccines Market Outlook?

Major companies operating in the cancer vaccines market include GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.

What Is Fueling Growth in the Cancer Vaccines Market?

The expected increase in global cancer cases constitutes a significant factor that could influence the expansion of the cancer vaccines market in the future. For instance, a prediction from the American Cancer Society in January 2022 states that the US could see approximately 1.9 million new cancer cases and around 609,360 deaths due to cancer, equating to an average of 1,670 deaths each day. Globally, the most prevalent types of cancer are lung, prostate, bowel, and breast cancer in females, which collectively represent 43% of all new cancer diagnoses. Consequently, the anticipated global rise in cancer occurrences is expected to stimulate the demand for the cancer vaccine market in the upcoming years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3452&type=smp

Which Cancer Vaccines Market Segments Are Growing the Fastest?

The cancer vaccines market covered in this report is segmented –

1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types

4) By End-User: Cancer Treatment Centers, Research Institutes

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines

2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines

Which Industry Trends Are Shaping the Future of the Cancer Vaccines Market?

The rising global popularity of alternative treatment methods and natural remedies is likely to hamper the revenue generated by companies manufacturing cancer vaccines. Homeopathy, Ayurveda, yoga, acupuncture and sujok therapy are witnessing an increased acceptance, gradually supplanting some traditional hospital procedures. For example, Ayurvedic medicine, a traditional Indian medical system, offers a wide array of techniques and treatments specifically for cancer. As the World Health Organization (WHO) reports, plant-based treatments remain the principal source of medicine in some countries, while developing countries are leveraging the benefits of natural compounds for therapeutic uses, a situation which is impacting the sales of cancer vaccines. In addition, projections suggest that the worldwide market for homeopathic products will reach the $18.6 billion mark by 2027. This tendency is expected to persist during the forecast period, thereby restricting the demand for cancer vaccines.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Which Countries Are Leading the Cancer Vaccines Market?

The countries covered in the cancer vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3452

This Report Delivers Insight On:

1. How big is the cancer vaccines market, and how is it changing globally?

2. Who are the major companies in the cancer vaccines market, and how are they performing?

3. What are the key opportunities and risks in the cancer vaccines market right now?

4. Which products or customer segments are growing the most in the cancer vaccines market?

5. What factors are helping or slowing down the growth of the cancer vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model